Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-25

Clinical Trial Update: The Effectiveness and Safety of 4% Sodium Citrate as a Lock Solution in Central Venous Hemodialysis Catheter [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating the effectiveness and safety of 4% sodium citrate lock solution in central venous hemodialysis catheters, focusing on cath…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium citrate 4% lock solution (sodium citrate)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Central Venous Catheter Thrombosis, Renal Dialysis | Phase 2, Phase 3 | Status: UNKNOWN